Business

Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd)

Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd)

Clas Ohlson Ab Class BJune 4, 20265
Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd)

About this update from Clas Ohlson Ab Class B

Light AI Inc NEO:ALGO : LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SAMD)

View stock analysis, news, and events for Clas Ohlson Ab Class B

More from Clas Ohlson Ab Class B

All Clas Ohlson Ab Class B news →